Scientist I, Neuroscience at Axsome Therapeutics Inc

Mountain View, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Neuroscience, Rare DiseasesIndustries

Requirements

Ph.D. in scientific discipline preferably in Neuroscience, Molecular Biology or Biochemistry with 1-2 years’ post-doctoral or Industry experience
Experience working with and/or establishing differentiated iPSCs
Excellent sterile technique and ability to establish and maintain various cell culture systems including primary and immortalized cell systems
Working knowledge of molecular biology (e.g., RT-PCR, qPCR, RNAseq) and gene editing techniques
Experience in protein quantification and analysis methods such as Western blot, ELISA, MSD
Exercises independent judgement within defined procedures and practices
Demonstrates technical proficiency and collaboration in a fast-paced, matrixed, team environment
Detailed and expert knowledge of scientific principles and concepts
Ability to work independently and collaboratively in multi-disciplinary teams
Ability to work on complex problems to produce experimental data across projects
Proficiency with Microsoft Office (preferably MS Excel and MS PowerPoint) and basic statistical analytical methods
Excellent verbal and written communication skills
Analytical thinker with excellent problem-solving skills
Understanding of strategic alignment with corporate goals and ability to adapt to changing priorities and deadlines
Excellent planning, organization, and time management skills

Responsibilities

With guidance from advisor, plans, initiates, directs, and executes scientific research and experiments, interprets and communicates results as part of multi-disciplinary teams, including analyses of primary research literature
Presents findings internally to cross-functional teams
May provide scientific advice to research leadership on projects and areas of expertise
Abides by all safety and regulatory guidelines and company SOPs
Maintains a detailed laboratory notebook
Performs other tasks as assigned
Interviews and contributes to the evaluation of candidates
May participate in the development and writing of patent applications
Contributes to general lab needs such as equipment maintenance, capital equipment purchases, and troubleshooting

Skills

iPSCs

sterile technique

scientific research

experiment planning

data analysis

literature review

cross-functional collaboration

lab notebook

equipment maintenance

troubleshooting

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters

2012Year Founded

$430.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Performance Bonus

Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.

Potential delays in AXS-07 launch amid growing market anticipation.

Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.

AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.

Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.

Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.

Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free